1 prescreening of genetic diseases (it’s worth & potential) dr pupak derakhshandeh, phd ass...
TRANSCRIPT
![Page 1: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/1.jpg)
11
Prescreening of Genetic Diseases
(It’s worth & potential)
Dr Pupak Derakhshandeh, PhD
Ass Prof of Medical Science of Tehran University
![Page 2: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/2.jpg)
22
Prescreening for• Down syndrome and trisomy 13 & 18• Breast cancer (BRCA1 AND BRCA2 GENES)• Colorectal cancer• SMA carrier testing• Factor V Leiden• Cardiovascular risk with C-reactive protein• and Apolipoprotein E
![Page 3: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/3.jpg)
33
Prescreening for Down syndrome and trisomy
21, 13 & 18
![Page 4: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/4.jpg)
44
Down Syndrome (Trisomy 21(
![Page 5: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/5.jpg)
55
Down SyndromeDown Syndrome (Trisomy 21 (Trisomy 21((
Trisomy 2Trisomy 2((
![Page 6: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/6.jpg)
66
First trimester screening for Down syndrome and trisomy 13 & 18
(up to12W) • The availability and acceptability of early
invasive diagnostic methods (eg, chorionic villus sampling, CVS)
• The continued need for second trimester screening for open fetal neural tube defects
![Page 7: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/7.jpg)
77
Women with singleton pregnancies: first-trimester combined screening
–measurement of Nuchal translucency
–pregnancy-associated plasma protein A [PAPP-A]
–The free beta subunit of human chorionic gonadotropin (HCG) at 10 weeks 3 days through 13 weeks 6 days of gestation
![Page 8: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/8.jpg)
88
Nuchal translucency screening involves the measurement by ultrasound of the skin
thickness at the back of the neck of a first
trimester fetus
![Page 9: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/9.jpg)
99
Identification about 85-90% of affected fetuses in the first-trimester
• maternal age was combined with fetal NT
• and maternal serum biochemistry (free β-HCG and pregnancy-associated plasma protein (PAPP-A)
![Page 10: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/10.jpg)
1010
![Page 11: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/11.jpg)
1111
Second-trimester (13-24W) quadruple screening
–measurement of:
• alpha-fetoprotein
• total human chorionic gonadotropin (HCG)
• unconjugated estriol
• inhibin A at 15 through 18 weeks of gestation
![Page 12: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/12.jpg)
1212
Maternal serum alpha-fetoprotein (MSAFP)
• fetus has two major blood proteins:
• albumin and alpha-fetoprotein (AFP)
• Since adults typically have only albumin in their blood
• the MSAFP test can be utilized to determine the levels of AFP from the fetus
![Page 13: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/13.jpg)
1313
MSAFP
• the gestational age must be known with certainty
• the amount of MSAFP increases with gestational age
• Neural tube defect
![Page 14: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/14.jpg)
1414
Neural tube defect (NTD)
• in the fetus:
• from failure of part of the embryologic neural tube to close
• there is a means for escape of more AFP into the amniotic fluid !
![Page 15: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/15.jpg)
1515
Note!
• the MSAFP can be elevated for a variety of reasons
• which are not related to fetal neural tube or abdominal wall defects, so this test is not 100% specific
![Page 16: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/16.jpg)
1616
Neural tube defect
![Page 17: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/17.jpg)
1717
Maternal blood sampling for fetal blood cells
• This is a new technique
• use of the phenomenon of fetal blood cells gaining access to maternal circulation through the placental villi
• only a very small number of fetal cells enter the maternal circulation in this fashion
![Page 18: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/18.jpg)
1818
Prenatal screening and diagnosis of neural tube defects
• Neural tube defects (NTD): second most prevalent congenital anomaly in the United States
• Two factors have played a significant role in the prevention of this disorder in developed countries: – Sonographic imaging combined with
amniocentesis for diagnosis of affected fetuses – folic acid supplements for prevention of the
disorder
![Page 19: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/19.jpg)
1919
Anencephaly (failure of closure at the cranial end of the neural tube)
![Page 20: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/20.jpg)
2020
Spina bifida (failure of closure at the caudal end of the neural tube)
![Page 21: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/21.jpg)
2121
Environmental factors• The frequency of NTDs is increased with
exposure to certain environmental factors:– drugs (valproic acid, carbamazepine, Folic acid
deficiency)– diabetes mellitus– Obesity
• Adequate folate is critical for cell division due to its essential role in the synthesis of:– nucleic– certain amino acids
![Page 22: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/22.jpg)
2222
Genetic factorsthe observations that NTDs have a high rate:
– in monozygotic twins– more frequent among first degree relatives– more common in females than males
• The risk of recurrence for NTDs: approximately 2
to 4 percent when there is one affected sibling
• With two affected siblings, the risk is approximately: 10 percent
• to be higher in countries such as Ireland
where the prevalence if NTDs is high
![Page 23: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/23.jpg)
2323
NOTE:• The genetic polymorphisms :
• mutations in the methylene tetrahydrofolate reductase gene
• may increase the risk for NTDs
• Folate is a cofactor for this enzyme
• which is part of the pathway of homocysteine metabolism in cells
• The C677T and the A1298C mutations are associated with elevated maternal homocysteine concentrations and an increased risk for NTDs in fetuses
![Page 24: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/24.jpg)
2424
Prevention of neural tube defects
• can be accomplished by supplementation of the maternal diet with only 4 mg of folic acid per day
• but this vitamin supplement must be taken a month before conception and through the first trimester
![Page 25: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/25.jpg)
2525
Maternal serum beta-HCG
• the beta-HCG can be used in conjunction with the MSAFP to screen for chromosomal abnormalities, and Down syndrome in particular
• An elevated beta-HCG coupled with a decreased MSAFP suggests Down syndrome
![Page 26: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/26.jpg)
2626
Maternal serum estriol
• made by the fetal adrenal glands
• Estriol tends to be lower when Down syndrome is present
![Page 27: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/27.jpg)
2727
Inhibin-A
• An increased level of inhibin-A is associated with an increased risk for trisomy 21
• A high inhibin-A may be associated with a risk for preterm delivery
![Page 28: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/28.jpg)
2828
Trisomy 21
MSAFP / beta-HCG
estriol / inhibin-A
![Page 29: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/29.jpg)
2929
overlapping are typical for trisomy 18
![Page 30: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/30.jpg)
3030
Prescreening BRCA1 AND BRCA2 GENES
![Page 31: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/31.jpg)
3131
BRCA1 AND BRCA2 GENES
• Breast cancer develops in about 12 percent of women who live to age 90
• a positive family history is reported by 15 to 20 percent of women with breast cancer
• They are associated with an inherited gene mutation
![Page 32: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/32.jpg)
3232
• Two major susceptibility genes for breast cancer, BRCA1 and BRCA2
• Testing for mutations in these genes, is available
• Clinicians and patients must decide when it is appropriate to screen for their presence
![Page 33: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/33.jpg)
3333
BRCA mutations• The reason why BRCA mutations
predispose mainly to breast and ovarian cancers is unclear
• intact BRCA1 represents a barrier to transcriptional activation of the estrogen receptor
• that functional inactivation could lead to altered hormonal regulation of mammary and ovarian epithelial proliferation
![Page 34: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/34.jpg)
3434
BRCA1 or / and BRCA2 gene abnormalities
• Cancer risk with a high penetrance
• women who have inherited mutations
• the lifetime risk of breast cancer is between 65 and 85 percent by age 70
![Page 35: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/35.jpg)
3535
Ovarian cancer
• Ovarian cancer is also linked to the presence of BRCA mutations
• the lifetime risk of ovarian cancer: – between 45 and 50 percent in women who
have a deleterious BRCA1 mutation– and 15 to 25 percent for those with a BRCA2
mutation
![Page 36: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/36.jpg)
3636
BRCA2-associated cancers
• prostate cancer• male breast cancer• pancreatic cancer • Although the risk of male breast cancer
and pancreatic cancer may be under 10 percent
• the risk of prostate cancer in BRCA2 carriers may be as high as 35 to 40 percent
![Page 37: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/37.jpg)
3737
![Page 38: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/38.jpg)
3838
BRCA 1
• The gene Locus for BRCA1: 17q21• a large gene• 24 exons • encoding a 220 kD • 1863 amino acids• Two recognizable motifs
![Page 39: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/39.jpg)
3939
BRCA2
• BRCA2 (13q12.3)
• was identified by Wooster et al. in 1995
• It encodes for 384 kD nuclear protein
• 3418 amino acids
• BRCA2 bears no homology to any known tumour supressor genes
• contains 27 exons
• spread over 70 kb of genomic DNA
![Page 40: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/40.jpg)
4040
BRCA1 Gene
![Page 41: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/41.jpg)
4141
BRCA2 Gene
![Page 42: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/42.jpg)
4242
SSCP
single strand conformation polymorphism
simplicity clearly by heteroduplex analysis (HA)
![Page 43: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/43.jpg)
4343
Pedigree of a selected family with breast cancer
![Page 44: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/44.jpg)
4444
SSCP AnalysisBRCA1 Exon 15, 4650delCA
![Page 45: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/45.jpg)
4545
Pedigree of a selected family with breast cancer
![Page 46: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/46.jpg)
4646
SSCP Analysis
BRCA1, Exon 20,Nt 5382
![Page 47: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/47.jpg)
4747
SSCP AnalysisExon 11pi BRCA1 MS R1347G
![Page 48: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/48.jpg)
4848
Breast Cancer Families
![Page 49: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/49.jpg)
4949
Significance of family history
• Degree of relatedness to affected relatives
• Number of affected relatives
• The age of the relative (s) when breast cancer occurred
• Whether there is a family history of ovarian cancer
![Page 50: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/50.jpg)
5050
Mutations in BRCA1/2 gene
![Page 51: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/51.jpg)
5151
Prescreening for colorectal cancer
![Page 52: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/52.jpg)
5252
![Page 53: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/53.jpg)
5353
Screening for colorectal cancer
• Colorectal cancer (CRC) is – common– Lethal– preventable disease (98%)
• It is infrequent before age 40
• the incidence rises progressively to 3.7/1000 per year by age 80
![Page 54: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/54.jpg)
5454
Clinical detection of increased risk
• Before deciding how to screen:• clinicians should decide whether the individual patient is at
average or increased risk • based on his or her medical and family history• A few simple questions are all that is necessary:• Have you ever had colorectal cancer or an adenomatous polyp• Have you had inflammatory bowel disease (Crohn disease)• Has a family member had colorectal cancer or an adenomatous
polyp• If so, how many• was it a first-degree relative (parent, sibling, or child)• and at what age was the cancer or polyp first diagnosed
![Page 55: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/55.jpg)
5555
Crohn’s disease
• an inflammatory bowel disease• causes inflammation of the
gastrointestinal tract in both men and women
• persistent diarrhea, abdominal pain, fever, and at times rectal bleeding
![Page 56: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/56.jpg)
5656
Crohn’s disease
![Page 57: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/57.jpg)
5757
screening for Colorectal cancer (CRC)
• Patients at highest risk with familial syndromes (HNPCC, FAP)
• should be screened for CRC with colonoscopy at frequent specified intervals
![Page 58: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/58.jpg)
5858
People at high risk
• a first-degree relative with colon cancer• or adenomatous polyp diagnosed at age
<60 years• or two first-degree relatives diagnosed at
any age• should be advised to have screening
colonoscopy starting at age 40 years• or 10 years younger than the earliest
diagnosis in their family• whichever comes first, and repeated every
five years
![Page 59: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/59.jpg)
5959
HNPCC
![Page 60: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/60.jpg)
6060
Microsatellite Instability (MIN) in Adenomas as a Marker for Hereditary
Nonpolyposis Colorectal Cancer
•Hereditary nonpolyposis colorectal cancer (HNPCC)
•the most common of the well-defined colorectal cancer syndromes
•HNPCC: accounting for at least 2% of the total colorectal cancer
•carrying a greater than 80% lifetime risk of cancer
![Page 61: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/61.jpg)
6161
![Page 62: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/62.jpg)
6262
![Page 63: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/63.jpg)
6363
Microsatellite instability (MIN)
• can be detected in approximately 90% of tumors from individuals with Hereditary Non-Polyposis Colorectal Cancer (HNPCC)
• MIN is also reported in approximately 15% of sporadic colorectal carcinomas
![Page 64: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/64.jpg)
6464
Mutations in the human mismatch repair genes
(MMR MLH1, MSH2, MSH6, PMS1, PMS2)
• responsible for the MIN of the HNPCC tumors
![Page 65: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/65.jpg)
6565
Reduction in cancer morbidity and mortality of HNPCC patients
• can be accomplished by appropriate clinical cancer screening of HNPCC patients with mutations in mismatch repair (MMR) genes
![Page 66: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/66.jpg)
6666
Germline mutation analysis
• In individuals with cancer
• mutation detection can be accomplished relatively efficiently by germline mutation analysis of individuals (blood) whose cancers show microsatellite instability (MIN)
![Page 67: 1 Prescreening of Genetic Diseases (It’s worth & potential) Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University](https://reader036.vdocument.in/reader036/viewer/2022062423/56649e715503460f94b6fc68/html5/thumbnails/67.jpg)
6767
• Among 378 adenoma patients• six (1.6%) had at least one MIN adenoma• Five out of the six patients (83%) had a
germline MMR gene (mismatch repair gene) mutation
• MIN analysis is a useful method of MIN analysis is a useful method of prescreening colorectal adenoma patients prescreening colorectal adenoma patients for HNPCCfor HNPCC
Microsatellite Instability in Adenomas as a Marker for Hereditary Nonpolyposis Colorectal Cancer Anu Loukola et al. American Journal of Pathology. 1999;155:1849-1853